Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NSD2 | O96028 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyrrolidine SCHEMBL28363734 | 0.87 | — | — | |
| Benzene SCHEMBL28845726 | 0.84 | — | — | |
| SCHEMBL364687 | 0.84 | — | — | |
| SCHEMBL31304107 | 0.82 | — | — | |
| SCHEMBL6358962 | 0.80 | — | — | |
| SCHEMBL6032163 | 0.80 | — | — | |
| SCHEMBL10839446 | 0.78 | CRBN (0.47) | — | |
| SCHEMBL10840979 | 0.77 | HDAC6 (0.36) | — | |
| SCHEMBL8665715 | 0.77 | — | — | |
| SCHEMBL10838386 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10888839-B2 | Average-density-adjustable structure, and material change and selective bonding process using same | KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION (KR) | 2021-01-12 | — | — | US | disclosed |
| US-20180185818-A1 | AVERAGE-DENSITY-ADJUSTABLE STRUCTURE, AND MATERIAL CHANGE AND SELECTIVE BONDING PROCESS USING SAME | KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION (KR) | 2018-07-05 | — | — | US | disclosed |
| US-20090088339-A1 | IDENTIFICATION OF ACTIVATED RECEPTORS AND ION CHANNELS | THE JOHNS HOPKINS UNIVERSITY | 2009-04-02 | — | — | US | disclosed |
| US-7462457-B2 | Identification of activated receptors and ion channels | JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE (US) | 2008-12-09 | — | — | US | disclosed |
| US-7393318-B2 | Methods and compositions for interaction trap assays | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2008-07-01 | — | — | US | disclosed |
| US-7297491-B2 | Methods and compositions for interaction trap assays | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2007-11-20 | — | — | US | disclosed |
| US-20060205017-A1 | Microorganism genomics, compositions and methods related thereto | HANDELSMAN JO | 2006-09-14 | — | — | US | disclosed |
| EP-1379642-A4 | ARRAYED TRANSFECTION METHOD AND USES RELATED THERETO | WHITEHEAD BIOMEDICAL INST (US) | 2006-04-19 | — | — | EP | disclosed |
| US-7029847-B2 | Detection dimerizing test polypeptide; obtain population of genetically engineered cells, express vector, isolate cells expressing desired concentration of reporter molecule | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2006-04-18 | — | — | US | disclosed |
| US-7008767-B2 | Microorganism genomics, compositions and methods related thereto | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2006-03-07 | — | — | US | disclosed |
| WO-1998013513-A2 | METHODS AND COMPOSITIONS FOR IDENTIFYING RECEPTOR EFFECTORS | CADUS PHARMACEUTICAL CORPORATION (US) | 1998-04-02 | — | — | WO | disclosed |
| WO-1998012339-A2 | VIRAL VECTORS AND THEIR USES | COLD SPRING HARBOR LABORATORY (US) | 1998-03-26 | — | — | WO | disclosed |
| EP-0815081-A1 | PIPERIDINYL-2-ALKYL SUBST. LINEAR POLYAMINES FOR THE REDUCTION OF INTRACELLULAR, ENDOGENIC POLYAMINE LEVELS SUCH AS PUTRESCINE, SPERMIDINE AND SPERMINE, AND THEIR IMPACT ON CELL PROLIFERATION | Novartis AG (CH) | 1998-01-07 | — | — | EP | disclosed |
| WO-1997049557-A1 | LITHOGRAPHIC PLATES | HORSELL GRAPHIC INDUSTRIES LIMITED (GB) | 1997-12-31 | — | — | WO | disclosed |
| US-5627215-A | Unsaturate amino compounds for use as anticancer and antiprotozoic agent | CIBA-GEIGY CORPORATION (US) | 1997-05-06 | — | — | US | disclosed |
| WO-1996028425-A1 | PIPERIDINYL-2-ALKYL SUBST. LINEAR POLYAMINES FOR THE REDUCTION OF INTRACELLULAR, ENDOGENIC POLYAMINE LEVELS SUCH AS PUTRESCINE, SPERMIDINE AND SPERMINE, AND THEIR IMPACT ON CELL PROLIFERATION | NOVARTIS AG (CH) | 1996-09-19 | — | — | WO | disclosed |
| US-5527681-A | Immobilized molecular synthesis of systematically substituted compounds | AFFYMAX TECHNOLOGIES N.V. (NL) | 1996-06-18 | — | — | US | disclosed |
| EP-0686143-A1 | UNSATURATE AMINO COMPOUNDS FOR USE AS ANTICANCER AND ANTIPROTOZOIC AGENT | Novartis AG (CH) | 1995-12-13 | — | — | EP | disclosed |
| WO-1995018091-A1 | UNSATURATE AMINO COMPOUNDS FOR USE AS ANTICANCER AND ANTIPROTOZOIC AGENT | CIBA-GEIGY AG (CH) | 1995-07-06 | — | — | WO | disclosed |
| US-5424186-A | Biosynthesis of oligonucleotides on solid substrate by irradiation of predefined segments to remove blocking agents; then coupling with nucleotide | AFFYMAX TECHNOLOGIES N.V. (AN) | 1995-06-13 | — | — | US | disclosed |